Next-Generation CRT Trials Will Target Heart Failure Prevention
This article was originally published in The Gray Sheet
Executive Summary
A bevy of clinical trials in development will reveal if cardiac resynchronization therapy (CRT) prevents the progression or even the initial onset of heart failure in at-risk patients